Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
Open Access
- 10 April 2025
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (5) , 100800
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Health and Medical Research Council (APP1101320)
- National Health and Medical Research Council (211086)
- National Health and Medical Research Council (358395)
- State Government of Victoria
- Bristol-Myers Squibb
This publication has 46 references indexed in Scilit:
- Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular riskClinical Research in Cardiology, 2023
- A plasma lipid signature predicts incident coronary artery diseaseInternational Journal of Cardiology, 2021
- Effect of statins on lipid metabolism-related microRNA expression in HepG2 cellsPharmacological Reports, 2021
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participantsAmerican Heart Journal, 2019
- High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk FactorsCell Chemical Biology, 2019
- Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low LevelsJAMA Cardiology, 2018
- Pleiotropy of cardiometabolic syndrome with obesity-related anthropometric traits determined using empirically derived kinships from the Busselton Health StudyHuman Genetics, 2017
- Missing Value Imputation Improves Mortality Risk Prediction Following Cardiac Surgery: An Investigation of an Australian Patient CohortHeart, Lung and Circulation, 2017
- A Century of Cholesterol and Coronaries: From Plaques to Genes to StatinsCell, 2015
- Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and SwedenEuropean Journal of Clinical Pharmacology, 1997